CLINICAL_TRIALS
trial_result
· 2026-06-26
Clinical Trial Results: Cough Reduction in IPF With Nalbuphine ER [Phase 2]
Summary
Phase 2 trial results evaluating nalbuphine ER for cough reduction in idiopathic pulmonary fibrosis have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Trevi Therapeutics | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2026-06-26